Jupiter doctor finds potential cure for MRSA - Fox29 WFLX TV, West Palm Beach, FL-news & weather

Jupiter doctor finds potential cure for MRSA

JUPITER, FL (WFLX) - Dr. Robert Berman knows he's on the brink of something big.

"This would be my greatest contribution to people in the whole world," says Dr. Berman. "Now, there's no better feeling than that."

Through a simple prescription gel he created, Dr. Berman hopes to stop the spread of MRSA, a stingy bacteria that can turn deadly.

"MRSA is just a very clever type of bacteria. It's a huge problem," he says.

Dr. Berman has dealt with MRSA in his patients for years. It's a bacteria that spreads quickly, especially through open wounds. In fact, 100,000 people die from MRSA each year in the U.S.

As a wound-care doctor, Berman has tried to find a way to stop it where it starts.

"And as a long as the MRSA was still there, the wounds wouldn't heal. So the frustration got to a point where it was like a nightmare," Dr. Berman recalls.

The Food and Drug Administration has given Dr. Berman the green light to run clinical trials for Vancogel. A big step for his creation that took 10 years to refine.

"Being a gel, it will then penetrate through the various crevasses and holes in an open wound," he says.

The gel can be put on cuts up to 50 centimeters deep. Right now, MRSA can only be treated by oral medication or by medication through an IV.

Trials will take place in Dr. Breman's Palm Beach County office. 100 people will take part in a process that will start August 1st and last through December.

If all goes well, Dr. Berman hopes his drug will be certified through the FDA. That would pave the way for Vancogel to be used in hospitals around the world.

Copyright 2011 WFLX. All Rights Reserved.

Powered by Frankly

1100 Banyan Blvd.
West Palm Beach, FL 33401

FCC Public File
EEO Report
Closed Captioning

All content © Copyright 2000 - 2017 Raycom Media. All Rights Reserved.
For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.